Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensive Care in India: The Indian Intensive Care Case Mix and Practice Patterns Study.
Divatia JV, Amin PR, Ramakrishnan N, Kapadia FN, Todi S, Sahu S, Govil D, Chawla R, Kulkarni AP, Samavedam S, Jani CK, Rungta N, Samaddar DP, Mehta S, Venkataraman R, Hegde A, Bande BD, Dhanuka S, Singh V, Tewari R, Zirpe K, Sathe P; INDICAPS Study Investigators. Divatia JV, et al. Among authors: sathe p. Indian J Crit Care Med. 2016 Apr;20(4):216-25. doi: 10.4103/0972-5229.180042. Indian J Crit Care Med. 2016. PMID: 27186054 Free PMC article.
Intensive Care in India in 2018-2019: The Second Indian Intensive Care Case Mix and Practice Patterns Study.
Divatia JV, Mehta Y, Govil D, Zirpe K, Amin PR, Ramakrishnan N, Kapadia FN, Sircar M, Sahu S, Bhattacharya PK, Myatra SN, Samavedam S, Dixit S, Pande RK, Mehta SN, Venkataraman R, Bajan K, Kumar V, Harne R, Thakur L, Rathod D, Sathe P, Gurav S, D'Silva C, Pasha SA, Todi SK; the INDICAPS-II investigators. Divatia JV, et al. Among authors: sathe p. Indian J Crit Care Med. 2021 Oct;25(10):1093-1107. doi: 10.5005/jp-journals-10071-23965. Indian J Crit Care Med. 2021. PMID: 34916740 Free PMC article.
Evolution Over Time of Ventilatory Management and Outcome of Patients With Neurologic Disease.
Tejerina EE, Pelosi P, Robba C, Peñuelas O, Muriel A, Barrios D, Frutos-Vivar F, Raymondos K, Du B, Thille AW, Ríos F, González M, Del-Sorbo L, Marín MDC, Valle Pinheiro B, Soares MA, Nin N, Maggiore SM, Bersten A, Amin P, Cakar N, Young Suh G, Abroug F, Jibaja M, Matamis D, Ali Zeggwagh A, Sutherasan Y, Anzueto A, Esteban A; VENTILA Group. Tejerina EE, et al. Crit Care Med. 2021 Jul 1;49(7):1095-1106. doi: 10.1097/CCM.0000000000004921. Crit Care Med. 2021. PMID: 33729719
A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin α1 as an Add-on Treatment to Existing Standard of Care Treatment in Moderate-to-severe COVID-19 Patients.
Shetty A, Chandrakant NS, Darnule RA, Manjunath BG, Sathe P. Shetty A, et al. Among authors: sathe p. Indian J Crit Care Med. 2022 Aug;26(8):913-919. doi: 10.5005/jp-journals-10071-24298. Indian J Crit Care Med. 2022. PMID: 36042753 Free PMC article.
HOW TO CITE THIS ARTICLE: Shetty A, Chandrakant NS, Darnule RA, Manjunath BG, Sathe P. A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin alpha1 as an Add-on Treatment to Exi …
HOW TO CITE THIS ARTICLE: Shetty A, Chandrakant NS, Darnule RA, Manjunath BG, Sathe P. A Double-blind Multicenter Two-arm Rand …
190 results